Project Title: Elucidating the mechanism by which MutY-Homolog knockdown kills pancreatic cancer cells
Principal Investigator: Dr. George Sharbeen
Position Held: Post-Doctoral Research Fellow - University of New South Wales
Project Summary: Pancreatic cancer is a deadly disease that urgently requires better treatments. Dr. Sharbeen and his team have identified a protein that, when inhibited, can kill pancreatic cancer cells and decrease their resistance to cancer drugs. This project will identify the mechanism(s) behind these effects. This information will help translate their target into the clinic.